TerrAscend Corp.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-06.
0001193125-26-337940
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-05.
0001193125-26-449749
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 11 previous paragraphs and 22 current paragraphs.
9 unchanged; 2 reworded; 10 added; 0 removed; 0 previous and 1 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
Investing in the Company's Common Shares involves a high degree of risk. Please refer to Part I, Item 1A, “Risk Factors” in the Company's Annual Report for a description of the material risks and uncertainties to which the Company’s business, financial condition and results of operations are subject. The Company may disclose changes to risk factors or disclose additional factors from time to time in its future filings with the SEC. Additional risks and uncertainties not presently known to the Company or that the Company currently deems immaterial may impair its business operations. There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” in the Company's Annual Report.
Added paragraphs (10)
Current report
(1) 240,500 of the shares purchased during August 2026 were purchased on or after August 24, 2026 when the Share Repurchase Program was renewed.
Current report
2026 Private Placement Convertible Debentures
Current report
On August 2, 2026, in a subsequent closing of the Debenture Offering, the Company entered into Debenture Subscription Agreements and issued 334 2026 Private Placement Convertible Debentures at a purchase price of $1,000 per debenture, for an aggregate principal amount of $334. These debentures have the same terms as the 2026 Private Placement Convertible Debentures issued on June 23 and June 30, 2026. They mature on September 30, 2031, bear interest at 8.00% per annum (with PIK Interest at the Company’s election), and are convertible at the holder’s option at any time before the Maturity Date into Common Shares at a conversion price of $0.87 per Common Share, subject to customary adjustments. After June 23, 2029, the Company may force conversion if the volume weighted average trading price of the Common Shares on the TSX for any 20 consecutive trading days equals or exceeds 200% of the then-applicable conversion price.
Current report
The 2026 Private Placement Convertible Debentures and any Common Shares issuable upon conversion or as interest thereon have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) and were offered and sold in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder
Current report
Aunt Mary's Issuance
Current report
On June 12, 2026, the Company and certain consolidated entities entered into an option agreement (the “Aunt Mary's Option Agreement”) with Aunt Mary's Dispensary LLC (“Aunt Mary’s”), a dispensary in New Jersey. On September 16, 2026, the Company closed on the transaction contemplated by the Aunt Mary's Option Agreement, and the Company was granted an option to purchase a 35% equity interest in Aunt Mary's (the “Aunt Mary's Option”) pursuant to the terms of the Aunt Mary's Option Agreement and New Jersey's regulatory framework, which facilitates investment opportunities for diversely owned businesses, which it exercised on September 23, 2026 (the “Aunt Mary's Transaction”).
Current report
On September 16, 2026, in connection with the Aunt Mary's Transaction, the Company issued a convertible promissory note (the “Aunt Mary's Convertible Promissory Note”) to the seller of Aunt Mary's in the aggregate principal amount of $3,000 (the “Aunt Mary's Principal Amount”). The Aunt Mary's Convertible Promissory Note accrues interest at a rate of 6.0% per annum, due in quarterly payments. The Aunt Mary's Convertible Promissory Note matures on September 15, 2031 (the “Aunt Mary's Maturity Date”).
Current report
Beginning on the third anniversary of the issuance of the Aunt Mary’s Convertible Promissory Note, if the Common Shares trade at a volume weighted average trading price of at least 200% of the conversion price for 20 consecutive trading days, the Issuer may, in its sole discretion, require the conversion of all or a portion of the outstanding Aunt Mary's Convertible Promissory Note, in intervals of at least $1. To exercise this right, the Issuer must provide the holder with at least 10 days' prior written notice. Upon conversion, the holder will be paid any accrued and unpaid interest on the converted principal through the conversion date in cash.
Current report
Prior to the Aunt Mary's Maturity Date, the Aunt Mary's Convertible Promissory Note may be converted, in intervals of at least $1, into Common Shares at the option of the holder. On the date of conversion, the Aunt Mary's Convertible Promissory Note will automatically convert into the number of Common Shares equal to the outstanding Aunt Mary's Principal Amount being converted divided by the conversion price per Common Share of $0.79.
Current report
The securities described above were offered and sold in reliance upon an exemption from registration provided by Section 4(a)(2) of the Securities Act. The Aunt Mary's Convertible Promissory Note and any Common Shares issuable thereunder have not been registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration with the SEC, or an applicable exemption from the registration requirements.
Reworded paragraphs (2)
Previous wording
On August 20, 2025, the Board approved the Share Repurchase Program, which replaced the Original Program. The Share Repurchase Program authorizes the Company to repurchase up to 10,000,000 Common Shares of the Company at any time, or from time to time, from August 22, 2025 until August 21, 2026. The Share Repurchase Program authorizes the Company to repurchase up to 60,255 Common Shares daily, which represents 25% of the Company’s average daily trading volume on the TSX of 241,023 Common Shares. Any repurchases under the program may be made by means of open market transactions, negotiated block transactions, or otherwise, including pursuant to a repurchase plan administered in accordance with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended. The size and timing of any repurchases will depend on price, market and business conditions, and other factors. During the second quarter of 2026, the Company repurchased Common Shares as set forth below:
Current wording
On August 20, 2026, the Board approved the Share Repurchase Program, which replaced the Previous Program. The Share Repurchase Program authorizes the Company to repurchase up to the lesser of 10,000,000 Common Shares or $10,000 of Common Shares at any time, or from time to time, from August 24, 2026 until August 23, 2027. The Share Repurchase Program authorizes the Company to repurchase up to 58,784 Common Shares daily, which represents 25% of the Company’s average daily trading volume on the TSX of 235,136 Common Shares. Any repurchases under the program may be made by means of open market transactions, negotiated block transactions, or otherwise, including pursuant to a repurchase plan administered in accordance with Rules 10b5-1 and 10b-18 under the
Previous wording
During the second quarter of 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted, modified, or terminated a Rule 10b5-1 trading arrangement.
Current wording
During the third quarter of 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended)adopted, modified, orterminated a Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
Securities Exchange Act of 1934, as amended. The size and timing of any repurchases will depend on price, market and business conditions, and other factors. During the third quarter of 2026, the Company repurchased Common Shares as set forth below: